Six medicines are licensed for ADHD in the UK, sold under more than a dozen brand names. This hub explains what each one is, who it is for, and how you actually get a prescription.
Three routes through this hub, depending on what you need to know.
Every licensed option belongs to one of two groups. They differ in how fast they work, how long they last, and how tightly they are regulated.
Group one
Stimulants
Stimulants increase the availability of dopamine and noradrenaline in the areas of the brain that manage attention and impulse control. They act quickly, often within an hour, so the effect of a dose change is clear within a day or two and titration can move at a reasonable pace.
Group two
Non-stimulants
Non-stimulants take a slower route. Atomoxetine blocks the reuptake of noradrenaline and builds a steady effect over four to eight weeks, so it needs patience and cannot be judged after a week. Guanfacine works on a different receptor system again.
Every medicine licensed for ADHD in the UK, with the brand names you will see written on a prescription.
Stimulants
Lisdexamfetamine. The longest-acting option, taken once each morning.
The most prescribed ADHD medicine in the UK, and the parent of six brands.
Modified-release methylphenidate using the OROS 22/78 system.
Modified release, 50/50. Taken with food.
Modified release, 30/70. Taken before breakfast.
Immediate-release methylphenidate, for cover over part of a day.
Immediate-release amfetamine. What Elvanse converts into in the body.
Bioequivalent to Concerta XL, and prescribed by brand.
Prolonged-release methylphenidate, also bioequivalent to Concerta XL.
Non-stimulants
Continuous cover. Takes four to eight weeks to reach full effect.
Licensed for children and adolescents where stimulants are unsuitable.
Used less often, and covered inside the non-stimulant guide.
Frequently asked about
Not licensed here and not on the NHS. Adderall XR can be imported privately at around £600 a month.
The licensed medicines differ mainly in how long they last and whether they are controlled drugs.
Scroll the table sideways to see every column.
Not sure which option applies to you?
A Consultant Psychiatrist can assess you and talk through whether medication fits. £695 online, £1,095 in person.
What the medicines do, what a good response feels like, and how the choice is made.
ADHD is associated with differences in how the brain uses two chemical messengers, dopamine and noradrenaline, in the networks handling attention, motivation and impulse control. Every medicine licensed here works on those two, by different routes and over different timescales.
People often expect something dramatic and are surprised by how ordinary it feels. A well-judged dose usually shows up as things becoming less effortful: starting a task without a long build-up, reading a page once rather than four times, leaving a meeting with a record of what was said. Many describe it as background noise dropping rather than anything being added.
It is worth being equally clear about what it does not do. Medication does not teach planning, and it will not build a system for remembering appointments. Those are learned skills. Our guide to what medication does and does not change covers this properly, and whether to medicate at all is a fair question with no single right answer.
Clinical context
What NICE guideline NG87 says
For adults, either lisdexamfetamine or methylphenidate is offered first. For children and young people aged five and over, methylphenidate is the usual first choice. Non-stimulants are considered where stimulants have not helped enough, are not tolerated, or are unsuitable.
NICE is also clear that medication should never be offered on its own. It belongs inside a wider plan that includes information about ADHD, environmental adjustments and psychological support.
No test predicts which medicine will suit a particular person, so the choice is made from clinical history rather than certainty. A Consultant Psychiatrist weighs how long cover is needed, whether sleep is already difficult, whether there is a history of anxiety, tics or a heart condition, and whether a controlled drug creates practical problems.
Formulation matters as much as the molecule. Two people can be prescribed methylphenidate and have entirely different days, because an immediate-release tablet and a modified-release capsule release the same drug on very different curves.
Worth knowing
The MHRA advises prescribing modified-release methylphenidate by brand rather than generically. Concerta XL, Medikinet XL and Equasym XL are not interchangeable, and an unintended brand switch can change how a day feels.
Response varies between individuals. Most people find a licensed option that helps meaningfully, but the first medicine tried is not always the one they stay on. Switching between medicines, or between formulations of the same medicine, is a normal part of treatment rather than a sign that something has gone wrong.
The route is the same whether you go through the NHS or privately. A GP cannot start ADHD medication.
Assessment
A diagnosis has to come before any prescription. Assessment is carried out by a specialist, such as a Consultant Psychiatrist.
Deciding whether to medicate
Taken together rather than assumed, and revisited later if circumstances change.
Titration
The dose is adjusted over several weeks, with baseline checks on height, weight, pulse and blood pressure. How titration works.
Ongoing review
Either with the specialist, or with your GP under a shared care agreement. That agreement is voluntary, and a practice can decline it.
The same licensed options, tried in a different order.
The licensed options are broadly the same, but the order they are tried in is not. For adults, lisdexamfetamine and methylphenidate are both first-line. For children and young people, methylphenidate comes first, and lisdexamfetamine is considered if a six-week trial at an adequate dose has not helped enough.
Adults often arrive at treatment having spent years building workarounds that partly mask the difficulty, which can make the first weeks confusing. What needs adjusting at that point is frequently the routine rather than the dose.
For children, the practical questions are usually about school: whether cover is needed for homework as well as lessons, who holds a midday dose, and how the school records it. Children also have height and weight tracked at every review, because stimulants can slow growth.
Side effects, timing, and the questions that come up once treatment has started.
Most side effects appear early, are mild, and settle within the first few weeks. Across the stimulants the common ones are reduced appetite, difficulty getting to sleep, dry mouth, headache and a modest rise in heart rate or blood pressure. Atomoxetine and guanfacine have their own patterns, with guanfacine more likely to cause drowsiness.
Timing solves more problems than people expect. Sleep difficulty is very often a dose taken too late rather than the wrong medicine, and appetite loss is frequently managed by moving meals rather than changing treatment. Both are worth raising at review before concluding that something is not working.
When to seek advice promptly
Chest pain, breathlessness, fainting, an irregular heartbeat, or any new or worsening thoughts of self-harm. Seek advice urgently if reality starts to feel distorted, for example hearing or seeing things that are not there or becoming unusually suspicious, or if mood becomes unusually elevated or overactive with little need for sleep. These are uncommon but should be reviewed rather than waited out. Do not stop any ADHD medication abruptly without advice, and note that guanfacine in particular is reduced gradually.
Methylphenidate, sold under brand names including Ritalin, Concerta XL, Medikinet and Equasym XL. Lisdexamfetamine, sold as Elvanse, is also widely prescribed and is a first-line option for adults.
A GP cannot start it. Treatment must be initiated by a specialist after a full assessment. Once the dose is stable, a GP may agree to continue prescribing under a shared care agreement, though practices can decline.
Not on the NHS, and not as a licensed medicine. Adderall XR can be prescribed privately by a specialist as an unlicensed imported medicine, at around £600 a month against £50 to £200 for the licensed options. The closest licensed equivalents are lisdexamfetamine and dexamfetamine.
Stimulants can take effect within about an hour of a suitable dose. Non-stimulants such as atomoxetine usually take four to eight weeks to reach full effect. Finding the right dose is a separate process and normally takes several weeks either way.
Taken as prescribed and monitored by a specialist, ADHD medication is not considered addictive, and treating ADHD is associated with a lower risk of substance misuse rather than a higher one. Stimulants are controlled medicines in the UK, so prescribing is carefully regulated.
No. Medication is one option among several, and some people manage well with coaching, therapy and adjustments alone. It is a decision to make with a Consultant Psychiatrist, and it can be revisited at any point.
Important
This information is general and educational. It is not a substitute for medical advice. Decisions about starting, changing or stopping ADHD medication are always made together with a Consultant Psychiatrist following a full assessment.
Considering an ADHD assessment?
Any conversation about medication starts with a diagnosis. Our GMC-registered Consultant Psychiatrists assess adults and children. Assessments are £695 online and £1,095 in person in London or Manchester. Adults can book an adult ADHD assessment online or in person.
No GP referral needed. Appointments are usually available within weeks.
References
Last reviewed September 2026. Next review due September 2027.